Very low-dosed solid oral dosage forms for HRT

Details for Australian Patent Application No. 2011240102 (hide)

Owner Bayer Intellectual Property GmbH

Inventors Mletzko, Stephan; Schurmann, Rolf; Gude, Kerstin

Agent Davies Collison Cave

Pub. Number AU-A-2011240102

PCT Pub. Number WO2011/128336

Priority 10160072.4 15.04.10 EP

Filing date 12 April 2011

Wipo publication date 20 October 2011

International Classifications

A61K 9/00 Medicinal preparations characterised by special physical form

A61K 9/14 Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 9/16 Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/19 Medicinal preparations characterised by special physical form - lyophilised

A61K 9/20 Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/565 - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

A61K 31/57 - substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone

A61P 15/12 Drugs for genital or sexual disorders

Event Publications

1 November 2012 PCT application entered the National Phase

  PCT publication WO2011/128336 Priority application(s): WO2011/128336

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011240113-Process for the preparation of 4- {4-[({[4 -chloro-3 -(trifluoromethyl)-phenyl]amino}carbonyl)amino]-3fluorophenoxy}-N-methylpyridine-2-carboxamide, its salts and monohydrate

2011240101-Method for heating up or keeping warm the flow paths of a process plant